RCOG Core Curriculum – Module 17 – Gynaecological Oncology
RCOG Guidelines
- Management of Endometrial Hyperplasia – GTG No. 67 – February 2016
- Guidelines for the Diagnosis and Management of Vulval Carcinoma – RCOG – May 2014
NICE Guidelines
- Ovarian cancer – The recognition and initial management of ovarian cancer – NICE CG122 – April 2011
- Laparoscopic radical hysterectomy for early stage cervical cancer – NICE IPG338- May 2010
RCOG – Other Publications
- Endometrial Cancer in Obese Women – RCOG Scientific Impact Paper No. 32 – May 2012
- Fertility Sparing Treatments in Gynaecological Cancers – RCOG Scientific Impact Paper No. 35 – February 2013
- Management of Female Malignant Ovarian Germ Cell Tumours – RCOG Scientific Impact Paper No.52 – November 2016
- Management of Women with a Genetic Predisposition to Gynaecological Cancers – RCOG Scientific Impact Paper No. 48 – February 2015
- Ovarian Cancer, Optimum Surgery in Advanced-stage – RCOG Scientific Impact Paper 25 – June 2011
- Progress in Cervical Screening – RCOG Scientific Impact Paper 7 – March 2016
- Reproductive Outcomes after Local Treatment for Preinvasive Cervical Disease – RCOG Scientific Impact Paper No.21 – July 2016
- Sentinel Lymph Node Biopsy in Endometrial Cancer – RCOG Scientific Impact Paper No.51 – July 2016
- Targeted therapies for the management of ovarian cancer – RCOG Scientific Impact Paper 12 – September 2013
TOG Articles
- Cervical cancer prevention and screening – the role of human papillomavirus testing – TOG 2016;18:251–63
- Diagnosing adnexal tumours before surgery – a critical appraisal of recent evidence – TOG 2015;17:163–71
- Fighting cervical cancer in under-resourced countries – TOG 2010;12:49–52
- FIGO staging in vulval and endometrial cancer – TOG 2010;12:245–249
- Management of borderline ovarian tumours – TOG 2012;14:115–120
- Non-cervical human papillomavirus-related disease – TOG 2013;15:221–6
- Pelvic exenteration for recurrent gynaecological cancer after radiotherapy – TOG 2017;19:109–18
- Risk-reducing surgery for women at high risk of epithelial ovarian cancer – TOG 2014;16:185–91
- Spotlight on gynaecological cancer – TOG 2014;16:231
- Squamous vulval cancer–an update – TOG 2013;15:227–31
- Surgical management of bowel obstruction in gynaecological cancer – TOG 2017;19:63–70
- The fallopian tube as the origin of non-uterine pelvic high-grade serous carcinoma – TOG 2016;18:143–52
- The molecular and genetic basis of inherited cancer risk in gynaecology – TOG 2015;17:233–41
- Treatment-related morbidity in gynaecological cancers – TOG 2010;12:79–86
- Update on chemotherapy in gynaecological cancers – TOG 2016;18:182–8
- Update on radiotherapy in gynaecological malignancies – TOG 2017;19:29–36
- Vulval intraepithelial neoplasia- making sense of the literature – TOG 2011;13:73–78
Miscellanous
- FIGO Ovarian Cancer Staging – 2014
- FIGO Staging for Carcinoma of the Vulva, Cervix, Endometrium, and Sarcomas – 2014
- NHS Cervical Screening Guideline 2016
- NHSCSP Good Practice Guide No 3 – HPV implementation guidance